Theravance Biopharma, Inc.
HealthcareNASDAQ:TBPH · NASDAQ Global Market
+$0.15 today
Vol 0.23M · Avg 0.44M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+55.66%
Period High
$20.74
Period Low
$10.57
Latest
$16.64
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Day One Biopharmaceuticals, Inc.
DAWN
$2.22B
Tyra Biosciences, Inc.
NASDAQ:TYRA
$1.61B
Vir Biotechnology, Inc.
NASDAQ:VIR
$1.45B
ArriVent BioPharma, Inc. Common Stock
NASDAQ:AVBP
$1.42B
Monte Rosa Therapeutics, Inc.
NASDAQ:GLUE
$1.19B
BlackRock Technology and Private Equity Term Trust
BTX
$1.05B
Geron Corporation
NASDAQ:GERN
$737.75M
Replimune Group, Inc.
NASDAQ:REPL
$733.24M
Valneva SE
NASDAQ:VALN
$507.78M
LENZ Therapeutics, Inc.
NASDAQ:LENZ
$212.27M
What is the latest TBPH filing?
The latest filing shown is 8-K dated Jun 12, 2026.
How many recent filings does TBPH have?
Intrinsic Alpha currently shows 20 recent filings for TBPH.
Explore More
Continue the stock analysis
Jump to another research area for this company.